Tag: male health

The efficacy of platelet rich plasma in the treatment of erectile dysfunction: a systematic review and meta-analysis of randomized controlled trials

This meta-analysis evaluated the efficacy of platelet-rich plasma (PRP) therapy in treating erectile dysfunction (ED) by analyzing four randomized controlled trials (RCTs) with 413 participants. PRP therapy significantly improved erectile function compared to placebo, as measured by the International Index of Erectile Function (IIEF) scores at one, three, and six

Read More »

Platelet-Rich Plasma (PRP) Improves Erectile Function: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

This study investigates the efficacy of Platelet-Rich Plasma (PRP) injections in improving erectile function in men with mild erectile dysfunction (ED). Conducted as a double-blind, randomized, placebo-controlled trial, it found that PRP treatment significantly improved erectile function compared to a placebo (p < 0.05). PRP is derived from the patient's

Read More »

Alterations in Pregnenolone and Testosterone Levels in Male Shift Workers

This study examines the effects of shift work on hormone levels in male workers, specifically focusing on pregnenolone and testosterone. It found that shift workers exhibited significantly lower serum levels of these hormones compared to daytime workers, likely due to disruptions in their circadian rhythms caused by irregular sleep-wake cycles.

Read More »

Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores

This meta-analysis evaluated the effects of testosterone therapy (TTh) on male sexual function using the International Index of Erectile Function (IIEF) scores. The results showed significant improvement in erectile function and sexual satisfaction in men with low testosterone, especially in those with initially low testosterone levels. Testosterone therapy was found

Read More »

Cardiovascular Safety of Testosterone-Replacement Therapy

This study evaluated the cardiovascular safety of testosterone replacement therapy in men aged 45-80 with hypogonadism and cardiovascular risk. It found that testosterone therapy did not increase cardiovascular risk, showing noninferiority to the placebo. This research supports the safety of testosterone for long-term use in men with metabolic concerns and

Read More »